Official Provider of NanoSALV Catalytic

Real People. Real Stories. Real Results.

From the communities we serve, to the systems we support, to the lives we change.

Communities

Healthcare Systems

Everyday Lives

The Power of CTM, Patient-Ready in NanoSALV Catalytic

NanoSALV Catalytic is a Canadian-made, Health Canada authorized medical device which optimizes skin and wound healing, reduces inflammation, and provides a broad-spectrum antimicrobial effect.

Used by physicians and surgeons across Canada, NanoSALV Catalytic is accessible across 2,500 hospitals and healthcare facilities and 14,000 pharmacies, nationwide.

Purchase Now

Improved wound healing by

~57.6%¹

Reduced wound care costs by

~46%²

Improved mental health and quality of life for patients and healthcare staff ³

Curious about where NanoSALV Catalytic could provide benefit for you?

Remember the 3 'i's. NanoSALV Catalytic is designed to provide benefit if your skin is:

Injured

Actively Promotes and

Optimizes Healing

(Breached Skin - Superficial, Partial or Full Thickness)

Inflamed

Reduces Inflammation

and Irritation

(Irritation, Redness, Blistering)

Alternative Technologies: Topical steroids

Infected

Provides Broad-Spectrum

Antimicrobial Effect

(Bacteria [including MSRSA], Virus, Fungi, Yeast, Biofilm)

Alternative Technologies: Antimicrobial dressings (silver, iodine), antiobiotic ointments

NanoSALV Catalytic’s versatile 3-in-1 technology helps simplify decision-making for both patients and clinicians, as it is suitable for skin that is injured, inflamed, and/or infected.

Real World Impact

eric_lab_photo_351c7b79-537f-4ad0-ab7f-038928a5ff20

NanoTess secures Government of Canada funding to adapt its validated Catalytic Technology for defence use

NanoTess signs deal with diabetes care leader embecta to bring catalytic wound care to all Canadians

Provincial coverage brings NanoSALV Catalytic to more Albertans in need of advanced wound care

Ottawa Citizen highlights a quality improvement project at Bruyère Health where NanoSALV helped heal wounds doctors thought would never heal

Discover how NanoSALV Catalytic can decrease wound/skin care costs, increase capacity and improve the physical and emotional wellbeing of your patients

Global News showcases how NanoTess is transforming healing with NanoSALV Catalytic, helping thousands of Canadians heal faster

HealthPRO Canada News captures how Carewest and NanoTess drove real change in skin health and wound care through partnership and purpose

CAN Health Network partners with Alberta Health Services and NanoTess to implement and evaluate NanoSALV Catalytic across multiple healthcare settings

Ontario-based GPO Mohawk Medbuy awards NanoTess an Innovation Contract, providing access of NanoSALV Catalytic to Canadian hospitals and health providers

Innovative NanoSALV Catalytic helping animals heal at Edmonton Zoo including 50-year-old Elephant Lucy

U of C's W21C leads pivotal study validating the effectivity, safety and ease of integration of the NanoSALV Catalytic Technology

Certified Aboriginal Business MSS Ltd. forges partnership with NanoTess in delivering advanced wound care to Indigenous communities, leaving no one behind

NanoSALV Catalytic Coverage

Private:

NanoSALV Catalytic is a medical device, so coverage is variable depending on each private plan. Health & Wellness spending accounts provide the most flexibility for medical device coverage.

Public (Alberta):

NanoSALV Catalytic (priced for 15g Unit only) is covered under the Alberta Drugs Benefit List. PIN/DIN is 00999688

Alberta Drug Benefit List

Contact Our Partner Success Team

Clinical research, economic evaluations, integration guides and FAQs are available to assist in the integration of NanoSALV Catalytic within your health care organization. Contact our partner success team for more information.

Canadian Made, Globally Compassionate

Your purchase supports limb-saving research to improve patient outcomes through catalytic innovations.

Where to Buy

Our Community & Supporters:

¹ W21C Research and Innovation. Centre Act to Improve Pressure Injuries in Alberta: Feasibility of Using NanoSALV Catalytic Advanced Wound Care Treatment Matrix to Treat Pressure Injuries and Chronic Wounds. 2023

² Institute of Health Economics, Executive Summary - Trial-based Economic Evaluation for the NanoSALV Catalytic Advanced Wound Care Treatment Matrix for the Management of Pressure Injuries, Diabetic Foot Ulcers, and Leg Ulcers, Table 5. Nov 2023.

³Bradford, A., Arnold, K., VanTil, K., de Grood, J., Ambler, K., Wickson, P., & Ho, C. (2025). Human factors evaluation of an innovative wound care technology. Human Factors in Healthcare. 8:100108.